SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Ondine Biomedical positive topline results in US Phase 3 study

Ondine Biomedical reported positive topline results from a US Phase 3 study.

OBI

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.